23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.

The David Rubenstein Show: Peer to Peer Conversations : BLOOMBERG : August 14, 2022 10:00am-10:30am EDT : Free Borrow & Streaming : Internet Archive

23andMe May Soon Offer A Test For A Colorectal Cancer Gene, After FDA Approval

SPAC Review: Potential, 23andMe Acquisition of VGAC, Artificial Intelligence & Genetics

23andMe DNA-Testing Firm Goes Public Following Branson Deal - Bloomberg

23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer's (SITC) 2022 Annual Meeting

23andMe CEO: 'The human genome revealed its secrets 20 years ago. It's time to fulfill its promise of personalized health care

23andMe is on sale for 50% off today

Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT

23andMe to Get a Makeover After Agreement with FDA